Prestige Consumer Healthcare Inc.PBH

Prestige Consumer Healthcare Inc. Fair Value Disclosure

10-KFiled May 9, 20252 min read
Fair Value Measurements
For certain of our financial instruments, including cash, accounts receivable, accounts payable and other current liabilities, the carrying amounts approximate their respective fair values due to the relatively short maturity of these amounts.

The Fair Value Measurements and Disclosures topic of the FASB ASC 820 requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market assuming an orderly transaction between market participants. The Fair Value Measurements and Disclosures topic established market (observable inputs) as the preferred source of fair value, to be followed by the Company's assumptions of fair value based on hypothetical transactions (unobservable inputs) in the absence of observable market inputs. Based upon the above, the following fair value hierarchy was created:

Level 1 - Quoted market prices for identical instruments in active markets;

Level 2 - Quoted prices for similar instruments in active markets, as well as quoted prices for identical or similar instruments in markets that are not considered active; and

Level 3 - Unobservable inputs developed by the Company using estimates and assumptions reflective of those that would be utilized by a market participant.

The market values have been determined based on market values for similar instruments adjusted for certain factors. As such, the 2021 Senior Notes, the 2019 Senior Notes and the Term B-5 Loans are measured in Level 2 of the above hierarchy (see summary below detailing the carrying amounts and estimated fair values of these instruments at March 31, 2025 and 2024).

March 31, 2025March 31, 2024
(In thousands)Carrying ValueFair ValueCarrying ValueFair Value
2019 Senior Notes$400,000 $392,000 $400,000 $389,000 
2021 Senior Notes600,000 537,750 600,000 522,750 
2012 Term B-5 Loans— — 135,000 135,506 

At March 31, 2025 and 2024, we did not have any assets or liabilities measured in Level 1 or 3. During 2025, 2024 and 2023, there were no transfers of assets or liabilities between Levels 1, 2 and 3.
Free Sentinel

Want the next Prestige Consumer Healthcare Inc. fair value disclosure the moment it drops?

Set a Sentinel and we'll alert you the moment Prestige Consumer Healthcare Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.

Track for free

About Fair Value Disclosures

Fair value disclosures classify all assets and liabilities measured at fair value into a three-level hierarchy: Level 1 (quoted market prices), Level 2 (observable inputs like yield curves), and Level 3 (unobservable inputs requiring management estimates). The proportion of Level 3 assets directly reflects how much of the balance sheet depends on internal models rather than market evidence.

Key signals: a growing Level 3 balance relative to total fair-value assets increases valuation uncertainty and earnings volatility risk. Watch for transfers between levels — assets moving from Level 2 to Level 3 often signal deteriorating market liquidity. Unrealized gains and losses on Level 3 positions flow through earnings or other comprehensive income, so large swings deserve scrutiny. For financial institutions, examine the sensitivity disclosures that show how Level 3 valuations change under alternative assumptions. Compare the fair value of debt against its carrying amount to gauge hidden leverage.

Other Available Disclosures

Income TaxesPP&ELeasesSegmentsCommitmentsStock CompensationNew Standards